Search research articles
Contact Us
Filters
Showing results (41-50 of 87) with videos related to
Page
of 9
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2009
Diethylstilbestrol (DES) retains activity and is a reasonable option in patients previously treated with docetaxel for castration-resistant prostate cancer
C Serrate, Y Loriot, T De La Motte Rouge, et al.
Prostate Cancer and Prostatic Diseases
|
October 15, 2014
Who dies from prostate cancer?
A Patrikidou, Y Loriot, J-C Eymard, et al.
Bulletin Du Cancer
|
December 22, 2009
[New drugs in metastatic castration-resistant prostate cancer]
L Albiges, Y Loriot, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2008
The postchemotherapy PSA surge syndrome
R Thuret, C Massard, M Gross-Goupil, et al.
BMC Cancer
|
March 1, 2016
Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer
C R Lindsay, S Le Moulec, F Billiot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2009
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
R de Crevoisier, K Slimane, T Messai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors
C Massard, A Kramar, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2009
Why do residents choose the medical oncology specialty? Implications for future recruitment--results of the 2007 French Association of Residents in Oncology (AERIO) Survey
Y Loriot, L Albiges-Sauvin, D Dionysopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2010
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy
B Besse, C Massard, V Haddad, et al.
British Journal of Cancer
|
August 19, 2010
A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
E Boven, C Massard, J P Armand, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 87) with videos related to
Sort By:
Page
of 9
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2009
Diethylstilbestrol (DES) retains activity and is a reasonable option in patients previously treated with docetaxel for castration-resistant prostate cancer
C Serrate, Y Loriot, T De La Motte Rouge, et al.
Prostate Cancer and Prostatic Diseases
|
October 15, 2014
Who dies from prostate cancer?
A Patrikidou, Y Loriot, J-C Eymard, et al.
Bulletin Du Cancer
|
December 22, 2009
[New drugs in metastatic castration-resistant prostate cancer]
L Albiges, Y Loriot, M Gross-Goupil, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 22, 2008
The postchemotherapy PSA surge syndrome
R Thuret, C Massard, M Gross-Goupil, et al.
BMC Cancer
|
March 1, 2016
Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer
C R Lindsay, S Le Moulec, F Billiot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 15, 2009
Early PSA decrease is an independent predictive factor of clinical failure and specific survival in patients with localized prostate cancer treated by radiotherapy with or without androgen deprivation therapy
R de Crevoisier, K Slimane, T Messai, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 30, 2012
Tumor marker kinetics predict outcome in patients with relapsed disseminated non-seminomatous germ-cell tumors
C Massard, A Kramar, J Beyer, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2009
Why do residents choose the medical oncology specialty? Implications for future recruitment--results of the 2007 French Association of Residents in Oncology (AERIO) Survey
Y Loriot, L Albiges-Sauvin, D Dionysopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 31, 2010
ERCC1 influence on the incidence of brain metastases in patients with non-squamous NSCLC treated with adjuvant cisplatin-based chemotherapy
B Besse, C Massard, V Haddad, et al.
British Journal of Cancer
|
August 19, 2010
A phase I, dose-finding study of sunitinib in combination with irinotecan in patients with advanced solid tumours
E Boven, C Massard, J P Armand, et al.
Page
of 9